Search Results - "Berkowska, M A"

Prediction of the anti-RhD donor population size for managerial decision-making by van Hoeven, L. R., Berkowska, M. A., Verhagen, O. J. H. M., Koffijberg, H., van der Schoot, C. E., Janssen, M. P.

“…Background Rhesus D (RhD)‐negative women pregnant with a RhD‐positive child receive prophylactic injections to prevent haemolytic disease of the newborn…”
Get full text

Impact of blood storage and sample handling on quality of high dimensional flow cytometric data in multicenter clinical research by Diks, A.M., Bonroy, C., Teodosio, C., Groenland, R.J., de Mooij, B., de Maertelaere, E., Neirynck, J., Philippé, J., Orfao, A., van Dongen, J.J.M., Berkowska, M.A.

“…Obtaining reliable and reproducible high quality data in multicenter clinical research settings requires design of optimal standard operating procedures. While…”
Get full text

Persistent polyclonal B-cell lymphocytosis: extensively proliferated CD27+IgM+IgD+ memory B cells with a distinctive immunophenotype by Berkowska, M A, Grosserichter-Wagener, C, Adriaansen, H J, de Ridder, D, Mirani-Oostdijk, K P, Agteresch, H J, Böttcher, S, Orfao, A, van Dongen, J J M, van Zelm, M C

Get full text

MO251HIGHLY SENSITIVE FLOW CYTOMETRIC DETECTION OF RESIDUAL B-CELLS AFTER RITUXIMAB IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS PATIENTS by Teng, Y K O, Van Dam, L, Oskam, Jelle, Kamerling, S W A, Arends, E J, Bredewold, Edwin, Berkowska@lumc.nl, M A, Van Dongen, J J M, Rabelink, T J, Van Kooten, Cees

“…Abstract Background and Aims B-cell depletion with rituximab (RTX) is an effective treatment for anti-neutrophil cytoplasmic antibodies (ANCA)-associated…”
Get full text